Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal dexmedetomidine for postoperative pain after vitrectomy
IRCT20200825048515N78Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial in postoperative pain comparing Intranasal dexmedetomidine with Intranasal placebo (2 arms). Primary endpoints: Pain score, Heart rate and 3 more. Started Jan 2025; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20200825048515N78.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200825048515N78.